Why Boston Scientific Corporation (BSX) Stock Fell 5.8% on Oct 28, 2026
What happened
Boston Scientific slashed earnings guidance following a cyberattack and other operational challenges, as reported by Barron's and The Wall Street Journal. The stock fell 7.63% to $41.62 in intraday trading. The guidance cut signals material near-term earnings pressure, though volume data remains unreliable this early in the session.
Monitor Q3 2026 earnings details from the PR Newswire filing and listen for management commentary on the cyberattack's scope, remediation timeline, and revised full-year outlook on earnings calls or investor updates.
Other developments that session
Boston Scientific Corporation (BSX) filed a new 8-K on October 28, 2026. We checked earnings releases, analyst updates, and corporate news — no specific event disclosure was found in available sources.
BSX reported Q3 EPS of $0.73, matching consensus estimates but declining 2.7% year-over-year.
Frequently asked questions
Why did Boston Scientific Corporation (BSX) stock fall on Oct 28, 2026?
Boston Scientific slashed earnings guidance following a cyberattack and other operational challenges, as reported by Barron's and The Wall Street Journal. The stock fell 7.63% to $41.62 in intraday trading. The guidance cut signals material near-term earnings pressure, though volume data remains unreliable this early in the session.
How much did BSX stock fall on Oct 28, 2026?
BSX fell 5.8% during the Oct 28, 2026 trading session.